| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Studies |
Department of Pathology and Laboratory Medicine (D.N.M., H.Y., E.P.D.), Mount Sinai Hospital, Toronto, Ontario M5G 1X5; Department of Clinical Biochemistry (D.N.M., H.Y., E.P.D.), University of Toronto, Toronto, Ontario M5G 1L5, Canada; and Department of Obstetrics and Gynecology (M.A., C.W., F.S.), Division of Reproductive Endocrinology and Infertility, University of Southern California School of Medicine, Los Angeles, California 90033
Address correspondence and requests for reprints to: Dr. E. P. Diamandis, Department of Pathology and Laboratory Medicine, 600 University Avenue, Toronto, Ontario, Canada, M5G 1X5.
Prostate-specific antigen (PSA) is present at very low concentrations
in female serum, but it can now be measured with highly sensitive
immunoassays. We have found that in female tissues the PSA gene is
regulated by steroid hormones through the action of steroid hormone
receptors. Thus, we examined whether female serum PSA is associated
with hyperandrogenic states. Serum PSA levels were compared between 22
hirsute women with a Ferriman-Gallwey score higher than 8 and 50 women
without hirsutism. The results show that PSA levels were higher in
hirsute women in comparison with controls. In hirsute women, levels of
PSA and 3
-androstanediol glucuronide (3
-AG), a specific
metabolite of androgen action, showed a significant positive
correlation, whereas PSA and 3
-AG showed a significant negative
correlation with patient age. Receiver operating characteristic (ROC)
analysis revealed that 3
-AG was a slightly better marker of androgen
excess than PSA. We conclude that female serum PSA may be a new
biochemical marker of androgen action in females.
This article has been cited by other articles:
![]() |
M. H. Slagter, A. Scorilas, L. J.G. Gooren, W. de Ronde, A. Soosaipillai, E. J. Giltay, M. Paliouras, and E. P. Diamandis Effect of Testosterone Administration on Serum and Urine Kallikrein Concentrations in Female-to-Male Transsexuals Clin. Chem., August 1, 2006; 52(8): 1546 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Aksoy, F. Akcay, Z. Umudum, A. K. Yildirim, and R. Memisogullari Changes of PSA Concentrations in Serum and Saliva of Healthy Women during the Menstrual Cycle Ann. Clin. Lab. Sci., January 1, 2002; 32(1): 31 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Obiezu, A. Scorilas, A. Magklara, M. H. Thornton, C. Y. Wang, F. Z. Stanczyk, and E. P. Diamandis Prostate-Specific Antigen and Human Glandular Kallikrein 2 Are Markedly Elevated in Urine of Patients with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1558 - 1561. [Abstract] [Full Text] |
||||
![]() |
H. F. Escobar-Morreale, S. Ávila, and J. Sancho Serum Prostate-Specific Antigen Concentrations Are Not Useful for Monitoring the Treatment of Hirsutism with Oral Contraceptive Pills J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2488 - 2492. [Abstract] [Full Text] |
||||
![]() |
C. V. Obiezu, E. J. Giltay, A. Magklara, A. Scorilas, L. J.G. Gooren, H. Yu, D. J.C. Howarth, and E. P. Diamandis Serum and Urinary Prostate-specific Antigen and Urinary Human Glandular Kallikrein Concentrations Are Significantly Increased after Testosterone Administration in Female-to-Male Transsexuals Clin. Chem., June 1, 2000; 46(6): 859 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Negri, F. Tosi, R. Dorizzi, A. Fortunato, G. G. Spiazzi, M. Muggeo, R. Castello, and P. Moghetti Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 81 - 84. [Abstract] [Full Text] |
||||
![]() |
V. H. H. Goh Breast Tissues in Transsexual Women-A Nonprostatic Source of Androgen Up-Regulated Production of Prostate-Specific Antigen J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3313 - 3315. [Abstract] [Full Text] |
||||
![]() |
A. SULLI, C. PIZZORNI, R. SCOTTO-BUSATO, S. ACCARDO, and M. CUTOLO Androgenizing Effects of Cyclosporin A in Rheumatoid Arthritis Ann. N.Y. Acad. Sci., June 22, 1999; 876(1): 391 - 396. [Full Text] [PDF] |
||||
![]() |
C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Escobar-Morreale, J. Serrano-Gotarredona, S. Avila, J. Villar-Palasí, C. Varela, and J. Sancho The Increased Circulating Prostate-Specific Antigen Concentrations in Women with Hirsutism Do Not Respond to Acute Changes in Adrenal or Ovarian Function J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2580 - 2584. [Abstract] [Full Text] |
||||
![]() |
D. N. Melegos and E. P. Diamandis Is Prostate-Specific Antigen Present in Female Serum? Clin. Chem., March 1, 1998; 44(3): 691 - 692. [Full Text] [PDF] |
||||
![]() |
G. M. Lambert-Messerlian, J. A. Canick, D. N. Melegos, and E. P. Diamandis Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome Clin. Chem., February 1, 1998; 44(2): 205 - 208. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |